15th Annual Optimising Clinical Trials Summit:
Site Selection, Feasibility & Patient Recruitment

13 - 14 October 2021 | London / Online

PAST SPEAKERS

SEE THE PREVIOUS SPEAKERS & CASE STUDIES

Marta GARCIA MANRIQUE

Chief Patient Officer, R&D

Karl-Ludwig RADEK

Ass. Director Global Clinical Operations

Jost LEEMHUIS

Head of Safety Science

Nadia LIM

Director, Site Intelligence

Terttu HARING

Global Head for Clinical Innovation

CONFERENCE TOPICS 2021

LOOK AT THE TOPICS THAT WERE DISCUSSED

  • Perspectives on how global pandemic impacted the clinical research field
  • Technologies and AI-enabled solutions in clinical trial feasibility and site selection
  • What is the clinical trial’s greatest enemy?
  • Shifts in clinical trial transparency regulations and expectations for the future?
  • How to use decentralised trials for study design optimisation?
  • Barriers to pharma companies’ R&D efforts
  • How the pharma industry’s use of trials has changed since the pandemic hit?
  • Current clinical data concepts and views
  • What are the needs during the drug development?

Designed for

Members of board, C-level, Senior/Global Vice Presidents, Directors, Heads of departments from pharma industry involved in:

  • Clinical Trials
  • Clinical Operations
  • Clinical Information
  • Clinical Development
  • Outsourced Trials
  • Clinical Study
  • Safety Science
  • Site Intelligence
  • Patient Centricity
  • Data Scientists
  • R&D Informatics
  • Clinical Innovations
  • Site Management
  • Clinical Management
  • Clinical Research
  • Global Safety
  • Risk Monitoring
  • Data Integrity
  • Feasibility
  • Patient Recruitment

Terttu HARING

Global Head for Clinical Innovation

CASE STUDY / DAY 1

Wearables in Clinical Trials: Friends or Foes?

As much as smartwatches, activity trackers and other ‘wearables’ to monitor health and wellbeing are used on a daily basis by millions around the world, the use of their connected devices in clinical trials remains limited. Let us take a close look and discuss use cases, prerequisites, risks and benefits – both from a scientific and an operational perspective.

  • Patient and site perspective on wearables
  • How to secure investigator oversight over collected data
  • What do the data really tell us?
  • Which use cases to pursue with wearables in clinical trials?
CASE STUDY / DAY 1

New Clinical Trial Formats – Opportunities & Challenges

New clinical trial formats are emerging. The global COVID-19 pandemic forced the clinical trial environment to think differently and to use remote or digital technologies to ensure trial continuation. While opportunities for new clinical trial formats are obvious, there are also challenges. Decentralised clinical trials are a revolution to the trial ecosystem, that has not changed for decades.

Karl-Ludwig RADEK

Ass. Director Global Clinical Operations

Jost LEEMHUIS

Head of Safety Science

CASE STUDY / DAY 2

Understanding Patients: Needs During Drug Development – The Patient Safety Perspective

The trust of the patient into the physician is the key factor for subscribing a new drug or a therapy and afterwards adherence to treatment. Here the efficacy of the new drug is as important as the new safety profile. Sometimes Safety is even more important than Efficacy. Patient engagement for patient safety works, when it is done already during the early stages of development and insights for patient safety are generated during clinical trials. It is a drug development problem.

  • Insights for patient safety
  • Patient related outcomes
  • Patient engagement
CASE STUDY / DAY 2

Building and Implementing Data-Driven Site Selection Approaches

The COVID-19 pandemic and the focus on diversity created new challenges for organisations further reinforcing the need to be agile and adapt to change. When it comes to data-driven site selection, this means the ability to quickly integrate new data sets and layered intelligence to drive site selection. In this presentation, we will show how we adapted to incorporate new data points including site interactions, and local insights into our site selection models.

Nadia LIM

Director, Site Intelligence

Marta GARCIA MANRIQUE

Chief Patient Officer, R&D

CASE STUDY / DAY 2

Incorporating Patients’ Views on Clinical Research: From Theory to Practice

Incorporation of patients’ views in the design of clinical research is evolving from a theoretical concept to a common practice across clinical research organisations. This new process requires adaptation and development of new abilities as well as incorporation of best practices. The presentation will cover practical examples and challenges from PE experience.

  • Patient engagement in clinical research a new reality in clinical research
  • Patient engagement requires adaptation and development of new abilities
  • Publication of PE activities could help to align positions and share best practices and experience

SPONSORS

Overall very professional event with a very diverse set of presentations, all relevant to the key issues faced by pharma companies today

Lead Protocol Review and Challenge at Boehringer Ingelheim

STAY UPDATED FOR THE 2022 EDITION

Provide Us With Your Contact Details and Our Team Will Get Back to You With All the Updates Regarding the Upcoming Edition of This Event.